Share price: 105.50p

Total Voting Rights

3rd June 2013

In conformity with the FSA’s Disclosure and Transparency Rules, Cello Group plc (“Cello” or the “Company”) confirms the following:

As at the close of business on 30 May 2013 Cello’s issued share capital consisted of 82,683,959 ordinary shares of 10 pence each (“Ordinary Shares”), all with voting rights. The Company holds 237,000 Ordinary Shares in treasury. The total number of current voting rights in the Company will therefore be 82,446,959 shares.

The above figure (82,446,959 Ordinary Shares) may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FSA’s Disclosure and Transparency Rules.

 

Enquiries:

Cello Group 020 7812 8460
Mark Scott, Chief Executive  
Mark Bentley, Finance Director  
   
Cenkos Securities 0207 397 8900
Bobbie Hilliam  
   
Buchanan  
Mark Edwards/ Nicola Cronk/ Clare Akhurst 020 7466 5000

Contact Us

Dianna Hillier

Dianna.Hillier@cellohealth.com

Phone 020 7812 8468

Address

Cello Health plc

Queens House

8-9 Queen Street

London

EC4N 1SP

Registered Office

Queens House

8-9 Queen Street

London

EC4N 1SP

Company Registered

in England no.05120150